Speaker(s): 

Ryley Uber, PharmD, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Juliann Savatt, MS. CGC, Geisinger - has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the utility of pharmacogenomics in clinical practice.

• List contact methods for the Geisinger pharmacogenomics consult service.

• Identify patients who may benefit from a pharmacogenomics service consult.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Cara McCormick, MPH; Adam Buchanan, MS, MPH, LCGC; Juliann Savatt, MS, LCGC; Melissa Kelly, MS, LCGC and Marc Williams, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant.